Hanmi, Sanfer Partner to Bring GLP-1 Therapy to Mexico Hanmi Pharmaceutical has signed an exclusive distribution agreement with Mexico-based Laboratorios Sanfer to introduce efpeglenatide, a GLP-1 therapy for obesity, alongside Hanmis Dapalon Family diabetes treatments, marking a step in the South Korean companys global expansion strategy focused on metabolic diseases
Paired with a clean routine, hydrating molecules and barrier lipids, youre addressing the core biology of aging skin not just smoothing it for a night
Spacing the supplements 2-3 hours apart may optimize individual absorption
This meticulous, step-by-step process is repeated for every part of the torso that may be included in the procedure, always considering how each area relates to the others in order to create a proportional and harmonious final result
pg/mL, picograms per milliliter
CLA ,